Get our free email newsletter with just one click

Defibrillator launches writer in residence scheme in collaboration with the Langham Hotel

Aisling Loftus and Gethin Anthony in The Hotel Plays at the Langham Hotel. Photo: Simon Annand
by -

Theatre company Defibrillator has announced a second collaboration with the Langham hotel in London and is launching a writer in residence scheme as part of the initiative.

It is hoped that the scheme will become an annual event.

Following the company’s debut collaboration with the Langham, The Hotel Plays, earlier this year, The 1865 Project will mark the hotel’s 150th anniversary by staging a new production within the hotel’s suites and public spaces.

The project will launch a new writer in residence award, with the first recipient tasked with creating the show for the Langham’s anniversary.

Writers are invited to submit ideas for the show before September 29 with the winner announced on October 27. The production will take place in March 2015.

The successful candidate will win £5,000 plus a hospitality package and benefits at the Langham worth £7,000.

Defibrillator artistic director James Hillier said: ““After such an amazing experience with the Langham on The Hotel Plays, I was over the moon when Defibrillator was asked to create a production to mark this significant anniversary of one of London’s most famous hotels.  It’s incredibly exciting to be launching a new writer in residence programme which we’d like to become a yearly fixture.”

We need your help…

When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.

The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.

We are fully independent, but this means we rely on revenue from readers to survive.

Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.